Simpler Grants.gov #HRSA-27-072

HRSA WISH cooperative agreement for women’s preventive health guidelines

HRSA is seeking applicants to lead a five-year initiative that strengthens women’s preventive health guidance and its use in care. - Government buyer: Health Resources and Services Administration (HRSA), Maternal and Child Health Bureau, Division of Women’s Health. - Opportunity: Women’s Initiative for Screening and Health (WISH), HRSA-27-072; one cooperative agreement is expected. - Work requested: Convene a multidisciplinary coalition, review evidence, recommend updates to HRSA-supported Women’s Preventive Services Guidelines, and share guidance and resources with clinicians, patients, health systems, educators, insurers, and communities—especially those with limited access to preventive care. - Optional supplements: Up to $250,000 per year for up to five years for each of two areas: guideline outreach and awareness; and emerging-issues research, implementation, and evaluation. Supplements are available only to the selected WISH awardee. - Funding: $1,000,000 is available for the base program. Potential total funding could reach $6,000,000 if both optional supplements are fully funded for five years. - Eligible applicants: Qualifying nonprofits, tribal organizations and governments, state and local governments, educational institutions, and for-profit organizations, including small businesses. - OEMs and vendors: No product manufacturers, OEMs, or commercial vendors are identified; this is a grant-funded cooperative agreement, not a product purchase. - Products and quantities: No products are requested.

Description

This cooperative agreement supports the Women's Initiative for Screening and Health (WISH), which aims to improve women's health across the lifespan by increasing access to preventive health services. The work includes coordinating a multidisciplinary coalition to review and recommend evidence-based updates to HRSA-supported women's preventive service guidelines, raise awareness of the guidelines, and increase their use in clinical practice. One award is expected, with total available program funding of $1,000,000 and a five-year period of performance.

View original listing